{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:37:53Z","timestamp":1786451873406,"version":"build-2736575974"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA023108"],"award-info":[{"award-number":["5P30CA023108"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["DP2GM149750"],"award-info":[{"award-number":["DP2GM149750"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-74989-8","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T20:42:42Z","timestamp":1782852162000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hierarchical lineage tracing reveals diverse pathways of cytarabine resistance"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3266-6363","authenticated-orcid":false,"given":"Rachel","family":"Saxe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6639-1817","authenticated-orcid":false,"given":"Hannah","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6790-3998","authenticated-orcid":false,"given":"Abigail C.","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0140-693X","authenticated-orcid":false,"given":"Fahiima","family":"Abdullahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0065-017X","authenticated-orcid":false,"given":"Zo\u00eb","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Emiliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8277-6512","authenticated-orcid":false,"given":"Aaron","family":"McKenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,30]]},"reference":[{"key":"74989_CR1","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.ccell.2018.08.007","volume":"34","author":"AL Boyd","year":"2018","unstructured":"Boyd, A. L. et al. Identification of chemotherapy-induced leukemic-regenerating cells reveals a transient vulnerability of human AML recurrence. Cancer Cell 34, 483\u2013498.e5 (2018).","journal-title":"Cancer Cell"},{"key":"74989_CR2","doi-asserted-by":"publisher","first-page":"2799","DOI":"10.1038\/s41375-021-01338-7","volume":"35","author":"LC Stetson","year":"2021","unstructured":"Stetson, L. C. et al. Single cell RNA sequencing of AML initiating cells reveals RNA-based evolution during disease progression. Leukemia 35, 2799\u20132812 (2021).","journal-title":"Leukemia"},{"key":"74989_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-19119-8","volume":"11","author":"K Morita","year":"2020","unstructured":"Morita, K. et al. Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics. Nat. Commun. 11, 1\u201317 (2020).","journal-title":"Nat. Commun."},{"key":"74989_CR4","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/leu.2016.286","volume":"31","author":"PN Ojamies","year":"2016","unstructured":"Ojamies, P. N. et al. Monitoring therapy responses at the leukemic subclone level by ultra-deep amplicon resequencing in acute myeloid leukemia. Leukemia 31, 1048\u20131058 (2016).","journal-title":"Leukemia"},{"key":"74989_CR5","doi-asserted-by":"crossref","unstructured":"Winer, E. S. & Stone, R. M. Novel therapy in Acute myeloid leukemia (AML): moving toward targeted approaches. Ther. Adv. Hematol. 10, 2040620719860645 (2019).","DOI":"10.1177\/2040620719860645"},{"key":"74989_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-023-00839-1","volume":"13","author":"G O\u00f1ate","year":"2023","unstructured":"O\u00f1ate, G. et al. Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort. Blood Cancer J. 13, 69 (2023).","journal-title":"Blood Cancer J."},{"key":"74989_CR7","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fped.2019.00463","volume":"7","author":"A Lonetti","year":"2019","unstructured":"Lonetti, A., Pession, A. & Masetti, R. Targeted therapies for pediatric AML: gaps and perspective. Front. Pediatr. 7, 463 (2019).","journal-title":"Front. Pediatr."},{"key":"74989_CR8","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.1182\/blood.2020004856","volume":"135","author":"AH Wei","year":"2020","unstructured":"Wei, A. H. et al. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial. Blood 135, 2137\u20132145 (2020).","journal-title":"Blood"},{"key":"74989_CR9","doi-asserted-by":"publisher","first-page":"4326","DOI":"10.1182\/bloodadvances.2019000937","volume":"3","author":"DA Pollyea","year":"2019","unstructured":"Pollyea, D. A., Amaya, M., Strati, P. & Konopleva, M. Y. Venetoclax for AML: changing the treatment paradigm. Blood Adv. 3, 4326\u20134335 (2019).","journal-title":"Blood Adv."},{"key":"74989_CR10","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nm.4439","volume":"24","author":"H Bolouri","year":"2018","unstructured":"Bolouri, H. et al. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions. Nat. Med. 24, 103\u2013112 (2018).","journal-title":"Nat. Med."},{"key":"74989_CR11","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3390\/children7020012","volume":"7","author":"J Chen","year":"2020","unstructured":"Chen, J. & Glasser, C. L. New and emerging targeted therapies for pediatric acute myeloid leukemia (AML). Children 7, 12 (2020).","journal-title":"Children"},{"key":"74989_CR12","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.3390\/cancers17233735","volume":"17","author":"D G\u00f6rlich","year":"2025","unstructured":"G\u00f6rlich, D., Lanwer, L., Sauerland, C., Krug, U. & Faldum, A. Characterizing overall survival of patients with acute myeloid leukemia: a competing risk analysis of SEER data covering 46 years. Cancers 17, 3735 (2025).","journal-title":"Cancers"},{"key":"74989_CR13","unstructured":"Larson, A. R. & Uy, G. Acute myeloid leukemia: Induction therapy in fit, younger adults. In: UpToDate, L\u00f6wenberg, B. (Section editor), Rosmarin, A.G. (Deputy editor). Wolters Kluwer. (2026). Accessed January 2026."},{"key":"74989_CR14","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.beha.2014.10.008","volume":"27","author":"GJ Ossenkoppele","year":"2014","unstructured":"Ossenkoppele, G. J. & Schuurhuis, G. J. MRD in AML: it is time to change the definition of remission. Best. Pract. Res. Clin. Haematol. 27, 265\u2013271 (2014).","journal-title":"Best. Pract. Res. Clin. Haematol."},{"key":"74989_CR15","doi-asserted-by":"crossref","unstructured":"Thol, F. & Ganser, A. Treatment of relapsed acute myeloid leukemia. Curr. Treat. Options Oncol. 21, 66 (2020).","DOI":"10.1007\/s11864-020-00765-5"},{"key":"74989_CR16","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1007\/s00277-023-05406-z","volume":"102","author":"S Jiang","year":"2023","unstructured":"Jiang, S. et al. Salvage hematopoietic stem cell transplantation for patients with higher leukemia burden in relapsed or refractory acute myeloid leukemia: a ten-year study. Ann. Hematol. 102, 3205\u20133216 (2023).","journal-title":"Ann. Hematol."},{"key":"74989_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22625-y","volume":"12","author":"TR Docking","year":"2021","unstructured":"Docking, T. R. et al. A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia. Nat. Commun. 12, 2474 (2021).","journal-title":"Nat. Commun."},{"key":"74989_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/s41375-024-02137-6","volume":"38","author":"JF Severens","year":"2024","unstructured":"Severens, J. F. et al. Mapping AML heterogeneity\u2014multi-cohort transcriptomic analysis identifies novel clusters and divergent ex-vivo drug responses. Leukemia 38, 751\u2013761 (2024).","journal-title":"Leukemia"},{"key":"74989_CR19","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1182\/bloodadvances.2021004962","volume":"6","author":"S Stratmann","year":"2022","unstructured":"Stratmann, S. et al. Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Adv. 6, 152\u2013164 (2022).","journal-title":"Blood Adv."},{"key":"74989_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.3324\/haematol.2022.280800","volume":"108","author":"P Stelmach","year":"2023","unstructured":"Stelmach, P. & Trumpp, A. Leukemic stem cells and therapy resistance in acute myeloid leukemia. Haematologica 108, 353\u2013366 (2023).","journal-title":"Haematologica"},{"key":"74989_CR21","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1038\/s41375-020-0710-7","volume":"34","author":"B Yan","year":"2020","unstructured":"Yan, B. et al. Low-frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia. Leukemia 34, 1816\u20131827 (2020).","journal-title":"Leukemia"},{"key":"74989_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.cell.2010.02.027","volume":"141","author":"SV Sharma","year":"2010","unstructured":"Sharma, S. V. et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 141, 69\u201380 (2010).","journal-title":"Cell"},{"key":"74989_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nature22794","volume":"546","author":"SM Shaffer","year":"2017","unstructured":"Shaffer, S. M. et al. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature 546, 431\u2013435 (2017).","journal-title":"Nature"},{"key":"74989_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-12983-z","volume":"10","author":"F Caiado","year":"2019","unstructured":"Caiado, F. et al. Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection. Nat. Commun. 10, 1\u201315 (2019).","journal-title":"Nat. Commun."},{"key":"74989_CR25","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1038\/s41586-024-07690-9","volume":"631","author":"GS Fran\u00e7a","year":"2024","unstructured":"Fran\u00e7a, G. S. et al. Cellular adaptation to cancer therapy along a resistance continuum. Nature 631, 876\u2013883 (2024).","journal-title":"Nature"},{"key":"74989_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature22993","volume":"547","author":"LI Shlush","year":"2017","unstructured":"Shlush, L. I. et al. Tracing the origins of relapse in acute myeloid leukaemia to stem cells. Nature 547, 104\u2013108 (2017).","journal-title":"Nature"},{"key":"74989_CR27","doi-asserted-by":"crossref","unstructured":"Quinn, J. J. et al. Single-cell lineages reveal the rates, routes, and drivers of metastasis in cancer xenografts. Science 371, eabc1944 (2021).","DOI":"10.1126\/science.abc1944"},{"key":"74989_CR28","doi-asserted-by":"crossref","unstructured":"Simeonov, K. P. et al. Single-cell lineage tracing of metastatic cancer reveals selection of hybrid EMT states. Cancer Cell 39, 1150-1162.e9 (2021).","DOI":"10.1016\/j.ccell.2021.05.005"},{"key":"74989_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf7907","volume":"353","author":"A McKenna","year":"2016","unstructured":"McKenna, A. et al. Whole-organism lineage tracing by combinatorial and cumulative genome editing. Science 353, aaf7907 (2016).","journal-title":"Science"},{"key":"74989_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.imlet.2017.10.004","volume":"192","author":"V Driss","year":"2017","unstructured":"Driss, V. et al. Sub-clonal analysis of the murine C1498 acute myeloid leukaemia cell line reveals genomic and immunogenic diversity. Immunol. Lett. 192, 27\u201334 (2017).","journal-title":"Immunol. Lett."},{"key":"74989_CR31","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.exphem.2006.01.015","volume":"34","author":"B Yin","year":"2006","unstructured":"Yin, B., Kogan, S. C., Dickins, R. A., Lowe, S. W. & Largaespada, D. A. Trp53 loss during in vitro selection contributes to acquired Ara-C resistance in acute myeloid leukemia. Exp. Hematol. 34, 631\u2013641 (2006).","journal-title":"Exp. Hematol."},{"key":"74989_CR32","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/blood.2021014472","volume":"139","author":"T Grob","year":"2022","unstructured":"Grob, T. et al. Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome. Blood 139, 2347\u20132354 (2022).","journal-title":"Blood"},{"key":"74989_CR33","doi-asserted-by":"publisher","first-page":"10782","DOI":"10.3390\/ijms221910782","volume":"22","author":"B George","year":"2021","unstructured":"George, B., Kantarjian, H., Baran, N., Krocker, J. D. & Rios, A. TP53 in acute myeloid leukemia: Molecular aspects and patterns of mutation. Int. J. Mol. Sci. 22, 10782 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"74989_CR34","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.3389\/fonc.2019.01373","volume":"9","author":"KG de la Cruz L\u00f3pez","year":"2019","unstructured":"de la Cruz L\u00f3pez, K. G., Toledo Guzm\u00e1n, M. E., S\u00e1nchez, E. O. & Garc\u00eda Carranc\u00e1, A. MTORC1 as a regulator of mitochondrial functions and a therapeutic target in cancer. Front. Oncol. 9, 1373 (2019).","journal-title":"Front. Oncol."},{"key":"74989_CR35","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1182\/blood-2011-11-393934","volume":"120","author":"Z Zeng","year":"2012","unstructured":"Zeng, Z. et al. Targeting of mTORC1\/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment. Blood 120, 2679\u20132689 (2012).","journal-title":"Blood"},{"key":"74989_CR36","doi-asserted-by":"publisher","first-page":"8127","DOI":"10.3390\/ijms21218127","volume":"21","author":"A Schulze","year":"2020","unstructured":"Schulze, A., Oshi, M., Endo, I. & Takabe, K. MYC targets scores are associated with cancer aggressiveness and poor survival in ER-positive primary and metastatic breast cancer. Int. J. Mol. Sci. 21, 8127 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"74989_CR37","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/1878-0261.13115","volume":"16","author":"G Donati","year":"2022","unstructured":"Donati, G. et al. Targeting mitochondrial respiration and the BCL2 family in high-grade MYC-associated B-cell lymphoma. Mol. Oncol. 16, 1132\u20131152 (2022).","journal-title":"Mol. Oncol."},{"key":"74989_CR38","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1016\/j.cell.2020.04.048","volume":"181","author":"S Bowling","year":"2020","unstructured":"Bowling, S. et al. An engineered CRISPR\/Cas9 mouse line for simultaneous readout of lineage histories and gene expression profiles in single cells. Cell 181, 1410 (2020).","journal-title":"Cell"},{"key":"74989_CR39","doi-asserted-by":"publisher","first-page":"2174","DOI":"10.1038\/s41588-024-01920-6","volume":"56","author":"JS Schiffman","year":"2024","unstructured":"Schiffman, J. S. et al. Defining heritability, plasticity, and transition dynamics of cellular phenotypes in somatic evolution. Nat. Genet. 56, 2174\u20132184 (2024).","journal-title":"Nat. Genet."},{"key":"74989_CR40","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s00277-018-3260-6","volume":"97","author":"S Park","year":"2018","unstructured":"Park, S. et al. Genome-wide genotype-based risk model for survival in core binding factor acute myeloid leukemia patients. Ann. Hematol. 97, 955\u2013965 (2018).","journal-title":"Ann. Hematol."},{"key":"74989_CR41","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.leu.2401067","volume":"12","author":"A Venditti","year":"1998","unstructured":"Venditti, A. et al. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia. Leukemia 12, 1056\u20131063 (1998).","journal-title":"Leukemia"},{"key":"74989_CR42","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/(SICI)1096-8652(199808)58:4<278::AID-AJH5>3.0.CO;2-N","volume":"58","author":"A Saxena","year":"1998","unstructured":"Saxena, A. et al. Biologic and clinical significance of CD7 expression in acute myeloid leukemia. Am. J. Hematol. 58, 278\u2013284 (1998).","journal-title":"Am. J. Hematol."},{"key":"74989_CR43","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1046\/j.1365-2141.2001.03139.x","volume":"115","author":"K Ogata","year":"2001","unstructured":"Ogata, K. et al. Reappraisal of the clinical significance of CD7 expression in association with cytogenetics in de novo acute myeloid leukaemia: short report. Br. J. Haematol. 115, 612\u2013615 (2001).","journal-title":"Br. J. Haematol."},{"key":"74989_CR44","doi-asserted-by":"publisher","first-page":"166268","DOI":"10.1016\/j.bbadis.2021.166268","volume":"1868","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression. Biochim. Biophys. Acta Mol. Basis Dis. 1868, 166268 (2022).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"74989_CR45","doi-asserted-by":"publisher","first-page":"1068094","DOI":"10.3389\/fonc.2022.1068094","volume":"12","author":"J Zhang","year":"2022","unstructured":"Zhang, J. et al. High expression level of the FTH1 gene is associated with poor prognosis in children with non-M3 acute myeloid leukemia. Front. Oncol. 12, 1068094 (2022).","journal-title":"Front. Oncol."},{"key":"74989_CR46","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1182\/blood.V71.1.242.242","volume":"71","author":"WT Dalton","year":"1988","unstructured":"Dalton, W. T. et al. HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71, 242\u2013247 (1988).","journal-title":"Blood"},{"key":"74989_CR47","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1073\/pnas.82.3.790","volume":"82","author":"D Wolf","year":"1985","unstructured":"Wolf, D. & Rotter, V. Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells. Proc. Natl. Acad. Sci. USA. 82, 790\u2013794 (1985).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74989_CR48","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.ccell.2023.10.008","volume":"41","author":"S Lambo","year":"2023","unstructured":"Lambo, S. et al. A longitudinal single-cell atlas of treatment response in pediatric AML. Cancer Cell 41, 2117\u20132135.e12 (2023).","journal-title":"Cancer Cell"},{"key":"74989_CR49","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.cels.2021.04.005","volume":"12","author":"D DeTomaso","year":"2021","unstructured":"DeTomaso, D. & Yosef, N. Hotspot identifies informative gene modules across modalities of single-cell genomics. Cell Syst. 12, 446\u2013456.e9 (2021).","journal-title":"Cell Syst."},{"key":"74989_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2016.112","volume":"6","author":"CM Csizmar","year":"2016","unstructured":"Csizmar, C. M., Kim, D.-H. & Sachs, Z. The role of the proteasome in AML. Blood Cancer J. 6, e503 (2016).","journal-title":"Blood Cancer J."},{"key":"74989_CR51","doi-asserted-by":"publisher","first-page":"23808","DOI":"10.1074\/jbc.270.40.23808","volume":"270","author":"M Groettrup","year":"1995","unstructured":"Groettrup, M. et al. The interferon-gamma-inducible 11 S regulator (PA28) and the LMP2\/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J. Biol. Chem. 270, 23808\u201323815 (1995).","journal-title":"J. Biol. Chem."},{"key":"74989_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1006\/scbi.2001.0404","volume":"12","author":"B Seliger","year":"2002","unstructured":"Seliger, B., Cabrera, T., Garrido, F. & Ferrone, S. HLA class I antigen abnormalities and immune escape by malignant cells. Semin. Cancer Biol. 12, 3\u201313 (2002).","journal-title":"Semin. Cancer Biol."},{"key":"74989_CR53","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4049\/jimmunol.167.3.1204","volume":"167","author":"JT Kurnick","year":"2001","unstructured":"Kurnick, J. T. et al. A novel autocrine pathway of tumor escape from immune recognition: melanoma cell lines produce a soluble protein that diminishes expression of the gene encoding the melanocyte lineage melan-A\/MART-1 antigen through down-modulation of its promoter. J. Immunol. 167, 1204\u20131211 (2001).","journal-title":"J. Immunol."},{"key":"74989_CR54","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.chembiol.2014.02.006","volume":"21","author":"M Raule","year":"2014","unstructured":"Raule, M. et al. PA28\u03b1\u03b2 reduces size and increases hydrophilicity of 20S immunoproteasome peptide products. Chem. Biol. 21, 470\u2013480 (2014).","journal-title":"Chem. Biol."},{"key":"74989_CR55","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1006\/excr.2000.5148","volume":"264","author":"NA Pham","year":"2001","unstructured":"Pham, N. A. & Hedley, D. W. Respiratory chain-generated oxidative stress following treatment of leukemic blasts with DNA-damaging agents. Exp. Cell Res. 264, 345\u2013352 (2001).","journal-title":"Exp. Cell Res."},{"key":"74989_CR56","doi-asserted-by":"publisher","first-page":"566","DOI":"10.3390\/biom4020566","volume":"4","author":"P Cascio","year":"2014","unstructured":"Cascio, P. PA28\u03b1\u03b2: the enigmatic magic ring of the proteasome? Biomolecules 4, 566\u2013584 (2014).","journal-title":"Biomolecules"},{"key":"74989_CR57","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.tranon.2020.100773","volume":"13","author":"D Ribatti","year":"2020","unstructured":"Ribatti, D., Tamma, R. & Annese, T. Epithelial-mesenchymal transition in cancer: a historical overview. Transl. Oncol. 13, 100773 (2020).","journal-title":"Transl. Oncol."},{"key":"74989_CR58","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-018-1539-y","volume":"16","author":"S Wu","year":"2018","unstructured":"Wu, S., Du, Y., Beckford, J. & Alachkar, H. Upregulation of the EMT marker vimentin is associated with poor clinical outcome in acute myeloid leukemia. J. Transl. Med. 16, 170 (2018).","journal-title":"J. Transl. Med."},{"key":"74989_CR59","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.3390\/ijms25042173","volume":"25","author":"L Varisli","year":"2024","unstructured":"Varisli, L. & Vlahopoulos, S. Epithelial-mesenchymal transition in acute leukemias. Int. J. Mol. Sci. 25, 2173 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"74989_CR60","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3390\/cells11040649","volume":"11","author":"D Greaves","year":"2022","unstructured":"Greaves, D. & Calle, Y. Epithelial mesenchymal transition (EMT) and associated invasive adhesions in solid and haematological tumours. Cells 11, 649 (2022).","journal-title":"Cells"},{"key":"74989_CR61","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.3390\/biomedicines12081915","volume":"12","author":"D Cuevas","year":"2024","unstructured":"Cuevas, D. et al. The role of epithelial-to-mesenchymal transition transcription factors (EMT-TFs) in acute myeloid leukemia progression. Biomedicines 12, 1915 (2024).","journal-title":"Biomedicines"},{"key":"74989_CR62","first-page":"1","volume":"2022","author":"J Qi","year":"2022","unstructured":"Qi, J. et al. Five EMT-related gene signatures predict acute myeloid leukemia patient outcome. Dis. Markers 2022, 1\u20138 (2022).","journal-title":"Dis. Markers"},{"key":"74989_CR63","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1182\/blood-2018-12-889725","volume":"133","author":"D Sasca","year":"2019","unstructured":"Sasca, D. et al. NCAM1 (CD56) promotes leukemogenesis and confers drug resistance in AML. Blood 133, 2305\u20132319 (2019).","journal-title":"Blood"},{"key":"74989_CR64","first-page":"3115","volume":"129","author":"BC Lim","year":"2016","unstructured":"Lim, B. C. et al. Prickle1 promotes focal adhesion disassembly in cooperation with the CLASP-LL5\u03b2 complex in migrating cells. J. Cell Sci. 129, 3115\u20133129 (2016).","journal-title":"J. Cell Sci."},{"key":"74989_CR65","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1007\/s00253-011-3865-3","volume":"93","author":"H Jin","year":"2012","unstructured":"Jin, H. et al. BMP2 promotes migration and invasion of breast cancer cells via cytoskeletal reorganization and adhesion decrease: an AFM investigation. Appl. Microbiol. Biotechnol. 93, 1715\u20131723 (2012).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"74989_CR66","doi-asserted-by":"publisher","first-page":"4932","DOI":"10.7150\/ijbs.76425","volume":"18","author":"P Zhang","year":"2022","unstructured":"Zhang, P. et al. CPNE8 promotes gastric cancer metastasis by modulating focal adhesion pathway and tumor microenvironment. Int. J. Biol. Sci. 18, 4932\u20134949 (2022).","journal-title":"Int. J. Biol. Sci."},{"key":"74989_CR67","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13294","volume":"35","author":"A \u0160karkov\u00e1","year":"2025","unstructured":"\u0160karkov\u00e1, A. et al. Microtubule-associated NAV3 regulates invasive phenotypes in glioblastoma cells. Brain Pathol. 35, e13294 (2025).","journal-title":"Brain Pathol."},{"key":"74989_CR68","doi-asserted-by":"publisher","first-page":"4963","DOI":"10.1182\/blood-2012-05-432260","volume":"120","author":"F Kocabas","year":"2012","unstructured":"Kocabas, F. et al. Meis1 regulates the metabolic phenotype and oxidant defense of hematopoietic stem cells. Blood 120, 4963\u20134972 (2012).","journal-title":"Blood"},{"key":"74989_CR69","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1042\/BST20210234","volume":"49","author":"M Abuhantash","year":"2021","unstructured":"Abuhantash, M., Collins, E. M. & Thompson, A. Role of the HOXA cluster in HSC emergence and blood cancer. Biochem. Soc. Trans. 49, 1817\u20131827 (2021).","journal-title":"Biochem. Soc. Trans."},{"key":"74989_CR70","doi-asserted-by":"publisher","first-page":"936","DOI":"10.18632\/oncoscience.279","volume":"2","author":"C Vitali","year":"2015","unstructured":"Vitali, C., Tripodo, C. & Colombo, M. P. MEF2C and SOCS2 in stemness regulation. Oncoscience 2, 936\u2013937 (2015).","journal-title":"Oncoscience"},{"key":"74989_CR71","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1158\/2159-8290.CD-17-1271","volume":"8","author":"FC Brown","year":"2018","unstructured":"Brown, F. C. et al. MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia. Cancer Discov. 8, 478\u2013497 (2018).","journal-title":"Cancer Discov."},{"key":"74989_CR72","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00277-023-05156-y","volume":"102","author":"H Zhuang","year":"2023","unstructured":"Zhuang, H. et al. Loss of IRF8 inhibits the growth of acute myeloid leukemia cells. Ann. Hematol. 102, 1063\u20131072 (2023).","journal-title":"Ann. Hematol."},{"key":"74989_CR73","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202101031","volume":"8","author":"D Li","year":"2021","unstructured":"Li, D. et al. IRF8 impacts self-renewal of hematopoietic stem cells by regulating TLR9 signaling pathway of innate immune cells. Adv. Sci. 8, e2101031 (2021).","journal-title":"Adv. Sci."},{"key":"74989_CR74","doi-asserted-by":"publisher","first-page":"756231","DOI":"10.3389\/fimmu.2021.756231","volume":"12","author":"JMP Grenier","year":"2021","unstructured":"Grenier, J. M. P., Testut, C., Fauriat, C., Mancini, S. J. C. & Aurrand-Lions, M. Adhesion molecules involved in stem cell niche retention during normal haematopoiesis and in acute myeloid leukaemia. Front. Immunol. 12, 756231 (2021).","journal-title":"Front. Immunol."},{"key":"74989_CR75","doi-asserted-by":"publisher","first-page":"311","DOI":"10.3390\/cancers11030311","volume":"11","author":"R Windisch","year":"2019","unstructured":"Windisch, R. et al. Oncogenic deregulation of cell adhesion molecules in leukemia. Cancers 11, 311 (2019).","journal-title":"Cancers"},{"key":"74989_CR76","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1158\/1535-7163.MCT-16-0719","volume":"16","author":"BZ Carter","year":"2017","unstructured":"Carter, B. Z. et al. Focal adhesion kinase as a potential target in AML and MDS. Mol. Cancer Ther. 16, 1133\u20131144 (2017).","journal-title":"Mol. Cancer Ther."},{"key":"74989_CR77","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.1073\/pnas.162104799","volume":"99","author":"GH Danet","year":"2002","unstructured":"Danet, G. H. et al. C1qRp defines a new human stem cell population with hematopoietic and hepatic potential. Proc. Natl. Acad. Sci. USA. 99, 10441\u201310445 (2002).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"74989_CR78","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1111\/ijlh.14348","volume":"46","author":"T Reuvekamp","year":"2024","unstructured":"Reuvekamp, T., Bachas, C. & Cloos, J. Immunophenotypic features of early haematopoietic and leukaemia stem cells. Int. J. Lab. Hematol. 46, 795\u2013808 (2024).","journal-title":"Int. J. Lab. Hematol."},{"key":"74989_CR79","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1074\/mcp.M112.021931","volume":"12","author":"F Bonardi","year":"2013","unstructured":"Bonardi, F. et al. A proteomics and transcriptomics approach to identify leukemic stem cell (LSC) markers. Mol. Cell. Proteom. 12, 626\u2013637 (2013).","journal-title":"Mol. Cell. Proteom."},{"key":"74989_CR80","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41375-019-0656-9","volume":"34","author":"IA Elcheva","year":"2020","unstructured":"Elcheva, I. A. et al. RNA-binding protein IGF2BP1 maintains leukemia stem cell properties by regulating HOXB4, MYB, and ALDH1A1. Leukemia 34, 1354\u20131363 (2020).","journal-title":"Leukemia"},{"key":"74989_CR81","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng, H. et al. The m6A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell 40, 1566\u20131582.e10 (2022).","journal-title":"Cancer Cell"},{"key":"74989_CR82","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1101\/gad.349284.121","volume":"36","author":"T Harada","year":"2022","unstructured":"Harada, T. et al. A distinct core regulatory module enforces oncogene expression in KMT2A-rearranged leukemia. Genes Dev. 36, 368\u2013389 (2022).","journal-title":"Genes Dev."},{"key":"74989_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41994-0","volume":"14","author":"H Mumme","year":"2023","unstructured":"Mumme, H. et al. Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia. Nat. Commun. 14, 6209 (2023).","journal-title":"Nat. Commun."},{"key":"74989_CR84","doi-asserted-by":"publisher","first-page":"e1002240","DOI":"10.1371\/journal.pcbi.1002240","volume":"7","author":"D Venet","year":"2011","unstructured":"Venet, D., Dumont, J. E. & Detours, V. Most random gene expression signatures are significantly associated with breast cancer outcome. PLoS Comput. Biol. 7, e1002240 (2011).","journal-title":"PLoS Comput. Biol."},{"key":"74989_CR85","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1002\/eji.201445243","volume":"45","author":"M Keller","year":"2015","unstructured":"Keller, M. et al. The proteasome immunosubunits, PA28 and ER-aminopeptidase 1 protect melanoma cells from efficient MART-126-35 -specific T-cell recognition: Antigen processing. Eur. J. Immunol. 45, 3257\u20133268 (2015).","journal-title":"Eur. J. Immunol."},{"key":"74989_CR86","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1111\/ejh.13488","volume":"105","author":"K Ku\u017eelov\u00e1","year":"2020","unstructured":"Ku\u017eelov\u00e1, K., Obr, A., Markov\u00e1, J. & Ga\u0161ov\u00e1, Z. Integrin expression and adhesivity to fibronectin in primary acute myeloid leukemia cells: Impact of NPM1 and FLT3 mutations. Eur. J. Haematol. 105, 578\u2013587 (2020).","journal-title":"Eur. J. Haematol."},{"key":"74989_CR87","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1182\/blood-2013-06-511527","volume":"123","author":"R Jacamo","year":"2014","unstructured":"Jacamo, R. et al. Reciprocal leukemia-stroma VCAM-1\/VLA-4-dependent activation of NF-\u03baB mediates chemoresistance. Blood 123, 2691\u20132702 (2014).","journal-title":"Blood"},{"key":"74989_CR88","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01241-z","volume":"15","author":"HL Mumme","year":"2023","unstructured":"Mumme, H. L. et al. Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia. Genome Med. 15, 83 (2023).","journal-title":"Genome Med."},{"key":"74989_CR89","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15817-5","volume":"11","author":"V Barbier","year":"2020","unstructured":"Barbier, V. et al. Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance. Nat. Commun. 11, 2042 (2020).","journal-title":"Nat. Commun."},{"key":"74989_CR90","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.coph.2020.08.006","volume":"54","author":"W-C Chen","year":"2020","unstructured":"Chen, W.-C., Hu, G. & Hazlehurst, L. A. Contribution of the bone marrow stromal cells in mediating drug resistance in hematopoietic tumors. Curr. Opin. Pharmacol. 54, 36\u201343 (2020).","journal-title":"Curr. Opin. Pharmacol."},{"key":"74989_CR91","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/gcc.22794","volume":"58","author":"JAI Thoms","year":"2019","unstructured":"Thoms, J. A. I., Beck, D. & Pimanda, J. E. Transcriptional networks in acute myeloid leukemia. Genes Chromosomes Cancer 58, 859\u2013874 (2019).","journal-title":"Genes Chromosomes Cancer"},{"key":"74989_CR92","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.0010028","volume":"1","author":"EC Forsberg","year":"2005","unstructured":"Forsberg, E. C. et al. Differential expression of novel potential regulators in hematopoietic stem cells. PLoS Genet. 1, e28 (2005).","journal-title":"PLoS Genet."},{"key":"74989_CR93","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s00441-007-0379-5","volume":"328","author":"P Wuchter","year":"2007","unstructured":"Wuchter, P. et al. Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells. Cell Tissue Res. 328, 499\u2013514 (2007).","journal-title":"Cell Tissue Res."},{"key":"74989_CR94","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1053\/hp.2000.6552","volume":"31","author":"S Lantu\u00e9joul","year":"2000","unstructured":"Lantu\u00e9joul, S. et al. NCAM (neural cell adhesion molecules) expression in malignant mesotheliomas. Hum. Pathol. 31, 415\u2013421 (2000).","journal-title":"Hum. Pathol."},{"key":"74989_CR95","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1053\/j.gastro.2008.02.023","volume":"134","author":"SC Schreiber","year":"2008","unstructured":"Schreiber, S. C. et al. Polysialylated NCAM represses E-cadherin-mediated cell-cell adhesion in pancreatic tumor cells. Gastroenterology 134, 1555\u20131566 (2008).","journal-title":"Gastroenterology"},{"key":"74989_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuint.2005.12.011","volume":"49","author":"R Seidenfaden","year":"2006","unstructured":"Seidenfaden, R., Krauter, A. & Hildebrandt, H. The neural cell adhesion molecule NCAM regulates neuritogenesis by multiple mechanisms of interaction. Neurochem. Int. 49, 1\u201311 (2006).","journal-title":"Neurochem. Int."},{"key":"74989_CR97","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exphem.2020.04.007","volume":"85","author":"A Lenard","year":"2020","unstructured":"Lenard, A. et al. Epigenetic regulation of protein translation in KMT2A-rearranged AML. Exp. Hematol. 85, 57\u201369 (2020).","journal-title":"Exp. Hematol."},{"key":"74989_CR98","doi-asserted-by":"publisher","first-page":"5377","DOI":"10.3390\/ijms24065377","volume":"24","author":"R Skopek","year":"2023","unstructured":"Skopek, R. et al. Choosing the right cell line for acute myeloid leukemia (AML) research. Int. J. Mol. Sci. 24, 5377 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"74989_CR99","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.3324\/haematol.2014.110775","volume":"100","author":"MA Sanders","year":"2015","unstructured":"Sanders, M. A. et al. RNA sequencing reveals a unique fusion of the lysine (K)-specific methyltransferase 2A and smooth muscle myosin heavy chain 11 in myelodysplastic syndrome and acute myeloid leukemia. Haematologica 100, e1\u2013e3 (2015).","journal-title":"Haematologica"},{"key":"74989_CR100","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","volume":"40","author":"D Bottomly","year":"2022","unstructured":"Bottomly, D. et al. Integrative analysis of drug response and clinical outcome in acute myeloid leukemia. Cancer Cell 40, 850\u2013864.e9 (2022).","journal-title":"Cancer Cell"},{"key":"74989_CR101","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","volume":"368","author":"Cancer Genome Atlas Research Networ","year":"2013","unstructured":"Cancer Genome Atlas Research Network et al. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N. Engl. J. Med. 368, 2059\u20132074 (2013).","journal-title":"N. Engl. J. Med."},{"key":"74989_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07584-1","volume":"9","author":"S Chaudhury","year":"2018","unstructured":"Chaudhury, S. et al. Age-specific biological and molecular profiling distinguishes paediatric from adult acute myeloid leukaemias. Nat. Commun. 9, 5280 (2018).","journal-title":"Nat. Commun."},{"key":"74989_CR103","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1182\/blood-2005-09-3724","volume":"107","author":"FR Appelbaum","year":"2006","unstructured":"Appelbaum, F. R. et al. Age and acute myeloid leukemia. Blood 107, 3481\u20133485 (2006).","journal-title":"Blood"},{"key":"74989_CR104","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1038\/s41591-018-0049-z","volume":"24","author":"E Haapaniemi","year":"2018","unstructured":"Haapaniemi, E., Botla, S., Persson, J., Schmierer, B. & Taipale, J. CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response. Nat. Med. 24, 927\u2013930 (2018).","journal-title":"Nat. Med."},{"key":"74989_CR105","doi-asserted-by":"publisher","DOI":"10.1242\/dev.200877","volume":"149","author":"A Rodriguez-Fraticelli","year":"2022","unstructured":"Rodriguez-Fraticelli, A. & Morris, S. A. In preprints: the fast-paced field of single-cell lineage tracing. Development 149, dev200877 (2022).","journal-title":"Development"},{"key":"74989_CR106","doi-asserted-by":"publisher","unstructured":"Winter, E., Emiliani, F., Cook, A., Abderrahim, A. & McKenna, A. H. BASELINE: A CRISPR base editing platform for mammalian-scale single-cell lineage tracing. bioRxivorg https:\/\/doi.org\/10.1101\/2025.03.19.644238 (2025).","DOI":"10.1101\/2025.03.19.644238"},{"key":"74989_CR107","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41586-022-04922-8","volume":"608","author":"J Choi","year":"2022","unstructured":"Choi, J. et al. A time-resolved, multi-symbol molecular recorder via sequential genome editing. Nature 608, 98\u2013107 (2022).","journal-title":"Nature"},{"key":"74989_CR108","doi-asserted-by":"publisher","first-page":"5183","DOI":"10.1016\/j.cell.2023.09.019","volume":"186","author":"L Li","year":"2023","unstructured":"Li, L. et al. A mouse model with high clonal barcode diversity for joint lineage, transcriptomic, and epigenomic profiling in single cells. Cell 186, 5183\u20135199.e22 (2023).","journal-title":"Cell"},{"key":"74989_CR109","doi-asserted-by":"publisher","DOI":"10.1126\/science.aat9804","volume":"361","author":"R Kalhor","year":"2018","unstructured":"Kalhor, R. et al. Developmental barcoding of whole mouse via homing CRISPR. Science 361, eaat9804 (2018).","journal-title":"Science"},{"key":"74989_CR110","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1021\/acssynbio.2c00126","volume":"11","author":"FE Emiliani","year":"2022","unstructured":"Emiliani, F. E., Hsu, I. & McKenna, A. Multiplexed assembly and annotation of synthetic biology constructs using long-read nanopore sequencing. ACS Synth. Biol. 11, 2238\u20132246 (2022).","journal-title":"ACS Synth. Biol."},{"key":"74989_CR111","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s00239-022-10083-z","volume":"91","author":"MS Johnson","year":"2023","unstructured":"Johnson, M. S., Venkataram, S. & Kryazhimskiy, S. Best practices in designing, sequencing, and identifying random DNA barcodes. J. Mol. Evol. 91, 263\u2013280 (2023).","journal-title":"J. Mol. Evol."},{"key":"74989_CR112","unstructured":"Sprouffske, K. Simple Metrics to Summarize Growth Curves [R package growthcurver version 0.3.1]. (2020)."},{"key":"74989_CR113","doi-asserted-by":"publisher","first-page":"e0146021","DOI":"10.1371\/journal.pone.0146021","volume":"10","author":"C Ritz","year":"2015","unstructured":"Ritz, C., Baty, F., Streibig, J. C. & Gerhard, D. Dose-response analysis using R. PLoS ONE 10, e0146021 (2015).","journal-title":"PLoS ONE"},{"key":"74989_CR114","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/bioinformatics\/btq033","volume":"26","author":"AR Quinlan","year":"2010","unstructured":"Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841\u2013842 (2010).","journal-title":"Bioinformatics"},{"key":"74989_CR115","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1038\/s41592-019-0433-8","volume":"16","author":"CS McGinnis","year":"2019","unstructured":"McGinnis, C. S. et al. MULTI-seq: sample multiplexing for single-cell RNA sequencing using lipid-tagged indices. Nat. Methods 16, 619\u2013626 (2019).","journal-title":"Nat. Methods"},{"key":"74989_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14049","volume":"8","author":"GXY Zheng","year":"2017","unstructured":"Zheng, G. X. Y. et al. Massively parallel digital transcriptional profiling of single cells. Nat. Commun. 8, 14049 (2017).","journal-title":"Nat. Commun."},{"key":"74989_CR117","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao, Y. et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat. Biotechnol. 42, 293\u2013304 (2024).","journal-title":"Nat. Biotechnol."},{"key":"74989_CR118","doi-asserted-by":"publisher","first-page":"979","DOI":"10.12688\/f1000research.73600.1","volume":"10","author":"P-L Germain","year":"2021","unstructured":"Germain, P.-L., Lun, A., Garcia Meixide, C., Macnair, W. & Robinson, M. D. Doublet identification in single-cell sequencing data using scDblFinder. F1000Res 10, 979 (2021).","journal-title":"F1000Res"},{"key":"74989_CR119","doi-asserted-by":"publisher","first-page":"100592","DOI":"10.1016\/j.xgen.2024.100592","volume":"4","author":"Z Zhang","year":"2024","unstructured":"Zhang, Z. et al. Synthetic DNA barcodes identify singlets in scRNA-seq datasets and evaluate doublet algorithms. Cell Genom. 4, 100592 (2024).","journal-title":"Cell Genom."},{"key":"74989_CR120","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/s41590-018-0276-y","volume":"20","author":"D Aran","year":"2019","unstructured":"Aran, D. et al. Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage. Nat. Immunol. 20, 163\u2013172 (2019).","journal-title":"Nat. Immunol."},{"key":"74989_CR121","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-021-02584-9","volume":"23","author":"S Choudhary","year":"2022","unstructured":"Choudhary, S. & Satija, R. Comparison and evaluation of statistical error models for scRNA-seq. Genome Biol. 23, 27 (2022).","journal-title":"Genome Biol."},{"key":"74989_CR122","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1874-1","volume":"20","author":"C Hafemeister","year":"2019","unstructured":"Hafemeister, C. & Satija, R. Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression. Genome Biol. 20, 296 (2019).","journal-title":"Genome Biol."},{"key":"74989_CR123","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv 060012. https:\/\/doi.org\/10.1101\/060012 (2016).","DOI":"10.1101\/060012"},{"key":"74989_CR124","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13059-020-02000-8","volume":"21","author":"MG Jones","year":"2020","unstructured":"Jones, M. G. et al. Inference of single-cell phylogenies from lineage tracing data using Cassiopeia. Genome Biol. 21, 1\u201327 (2020).","journal-title":"Genome Biol."},{"key":"74989_CR125","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1093\/bioinformatics\/btv053","volume":"31","author":"E Zorita","year":"2015","unstructured":"Zorita, E., Cusc\u00f3, P. & Filion, G. J. Starcode: sequence clustering based on all-pairs search. Bioinformatics 31, 1913\u20131919 (2015).","journal-title":"Bioinformatics"},{"key":"74989_CR126","doi-asserted-by":"publisher","unstructured":"Shen, L., IsoMaM, S. GeneOverlap: test and visualize geneoverlaps. https:\/\/doi.org\/10.18129\/B9.bioc.GeneOverlap. R package version 1.48.0, https:\/\/bioconductor.org\/packages\/GeneOverlap (2026).","DOI":"10.18129\/B9.bioc.GeneOverlap"},{"key":"74989_CR127","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/molbev\/msw046","volume":"33","author":"J Huerta-Cepas","year":"2016","unstructured":"Huerta-Cepas, J., Serra, F. & Bork, P. ETE 3: reconstruction, analysis, and visualization of phylogenomic data. Mol. Biol. Evol. 33, 1635\u20131638 (2016).","journal-title":"Mol. Biol. Evol."},{"key":"74989_CR128","unstructured":"Therneau, T. M. Survival Analysis [R package survival version 3.8-3]. (2024)."},{"key":"74989_CR129","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/nar\/30.1.207","volume":"30","author":"R Edgar","year":"2002","unstructured":"Edgar, R., Domrachev, M. & Lash, A. E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 30, 207\u2013210 (2002).","journal-title":"Nucleic Acids Res"},{"key":"74989_CR130","doi-asserted-by":"publisher","unstructured":"Saxe, R., McKenna, A. & Stuart, H. Hierarchical Lineage Tracing Reveals Diverse Pathways of Cytarabine Resistance. Mckennalab\/AML_lineage_tracing: Paper Archive. Zenodo, https:\/\/doi.org\/10.5281\/ZENODO.19303230 (2026).","DOI":"10.5281\/ZENODO.19303230"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74989-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74989-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74989-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T12:03:58Z","timestamp":1786449838000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-74989-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,30]]},"references-count":130,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["74989"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-74989-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,30]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8147"}}